The European Research Organisation on Genital Infection and Neoplasia (EUROGIN) is kindly inviting you to participate in the 2015 International Multidisciplinary Congress EUROGIN, held February 4 – 7, 2014 in Sevilla, Spain.
The EUROGIN 2015 Congress aims at developing a full review of current scientific developments in the field of cervical cancer and human papillomavirus related diseases, raising the public health profile and increasing the need for responsible health services in this area.
Speakers include international leaders from academic, government and private organizations, representatives of medical and scientific societies, as well as women’s health associations who will discuss and exchange ideas on issues relevant to both individuals and public health.
The event endeavors to translate scientific and evidence-based research into clinical practice while highlighting the following aspects:
- Recent advances and updated scientific insights in HPV screening, testing and management
- The impact of HPV and associated cancers on public health
- Strategies to prevent and treat HPV related diseases
- Exchanging information on early detection, new diagnostic and therapeutic procedures and prevention strategies including screening and HPV vaccination
The EUROGIN congress offers a top-quality and innovative scientific program addressing highly relevant topics. One of the main strengths of the meeting consists of the fact that it gathers outstanding international representatives from the academic sector, professional and patient organizations around the same table. The event’s main objective consists of accelerating the translation of scientific dicoveries into day-to-day practice. Other objectives of the scientific program (training courses, plenary sessions, scientific sessions) are:
- Review the burden and epidemiology of HPV associated diseases in lower genital tract, anus and head & neck.
- Understanding the role of molecular testing in primary screening and prevention and their application in routine practice
- A review of recent developments in HPV infection, cancer prevention and control, including vulvar, anal and head & neck HPV induced diseses.
- Integrate the use of HPV prophylactic vaccines into clinical practice.
- Understanding the impact and cost-effectiveness of HPV prophylactic vaccines on public health
- Enhancing knowledge and updating scientific insights in the HPV risk management and testing
- Implementation of guidelines for cervical disease; screening and management of cervical abnormalities.
- Uses of HPV DNA and mRNA testing in clinical practice in a rational and cost-effective way.
- Review different tools and techniques available in the field of HPV infection diagnosis and adapt the most appropriate strategies for patients.
- Anticipate trends in biomarkers and genotyping for diagnosis and prevention.
- Compare worldwide experience in the field of screening and prevention of cervical disease, including developed and developing countries.
- Apply skills to enable the improvement, expansion, and use of scientific data for decision making
- Determine the public health role of physicians in HPV associated cancer control: prevention through training, early detection, treatment and quality of life.
- Identify existing strategies and explore innovative community interventions for HPV associated cancer screening outreach, future management and public education.
- Provide a learning environment for clinicians entering the field of cancer prevention and control where they can interact informally with all the leaders in this area.
- Advocacy, acceptability and psychology
- Anal neoplasia
- Automation in cytology
- Cervical neoplasia
- Conventional therapies
- Diagnostic procedures
- Economics and modelling
- Epidemiology and natural history
- Genital warts
- Health education
- HPV and associated skin diseases
- HPV and oropharynx /Head and neck cancer
- HPV prophylactic vaccines: basic science
- HPV prophylactic vaccines: clinical aspects
- HPV testing
- HPV therapeutic vaccines
- Liquid based cytology
- Low resource settings
- Molecular markers
- New technologies
- New treatments — Immunotherapy
- Oral HPV infection
- Screening methods
- Sexually transmitted diseases and HIV infection
- Vaginal neoplasia
- Viral and molecular biology
- Vulvar diseases and neoplasia
The EUROGIN 2015 congress is designed for health professionals from all over the world interested in HPV infections and related diseases: clinicians, gynecologists, dermatologists, gastroenterologists, otorhinolaryngologists, epidemiologists, virologists, cytopathologists, oncologists, health communication specialists, healthcare decision makers, governmental and non-governmental institutions.